Has Thomas Trumble, MD received payments from drug or device companies?

Yes. Drug and device makers reported $824,111 in general payments to Thomas Trumble, MD across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Trumble, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Trumble, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Trumble, MD

Hand Surgery · Bellevue, WANPI 1114003837

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $806,171 of the $824,111 with a category attached, or 97.8%. Arthrex accounts for 81.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $193,980 and has fallen 79.0% since, to $40,762 in 2025. Among hand surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$824,111in general payments, 2019–2025

Across 104 payments — averaging $7924.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$674K
Trimed, Inc.$139K
Summit Surgical Corp.$6K
Axogen$2K
Ensemble Orthopedics, Inc$1K
Linvatec Corporation$750
plus $1K from 12 others

What the payments were for

Royalty or licence$806,17198%
Consulting fees$7500%
Travel & lodging$7,9641%
Food & beverage$3,2260%
Education$6,0001%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	22	$674,384
Trimed, Inc.	30	$138,982
Summit Surgical Corp.	5	$6,000
Axogen	5	$1,674
Ensemble Orthopedics, Inc	10	$1,202
Linvatec Corporation	2	$750
Zimmer Biomet	9	$356
Skeletal Dynamics Inc	2	$228
Amniox Medical, Inc.	5	$134
Acera Surgical, Inc.	1	$79
Integra Lifesciences Corporation	2	$73
Orthofix Medical, Inc.	3	$65
Endo Pharmaceuticals Inc.	3	$49
Medartis Inc.	1	$39
Anika Therapeutics, Inc.	1	$31
Sientra, Inc.	1	$28
Nevro Corp.	1	$21
Tenex Health Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$2,288,306
DISTAL EXTREMITIES IMPLANTS HAND & WRIST DISTAL RADIUS$154,274
DISTAL EXTREMITIES IMPLANTS TRAUMA DISTAL RADIUS$57,631
Tools - WFS$24,160
Tools - AFS$10,751
AxoGuard Nerve Connector$1,651
AxoGuard Nerve Protector$1,651
Ensemble CMC$892
TRUESHOT$750
Geminus$228
Align$228
IJS$228
Implate$228
Comp Primary Revision Stem$115

How this compares

$824,111 in reported general payments places this provider in the 95th percentile of 75 hand surgery providers in Washington.

See all hand surgery providers in Washington →

Medicare billing

Part B allowed, 2024

$300,938

Medicare patients

257

Services billed

2,140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	82	$447
Ondansetron OdtOndansetron	81	$362
Cephalexin	22	$243
Celecoxib	13	$199
Ketorolac Tromethamine	34	$180
Hydroxyzine Pamoate	55	$140
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$136
Tramadol Hcl	17	$37

Paid to pharmacies, not to this prescriber.

Other hand surgery in Bellevue

Mary ThayerBellevue$51K
Grant LohseBellevue$4K
Cameron SchickBellevue$1K
Matthew LyonsBellevue$1K
David ZeltserBellevue$1K
Jerry HuangSeattle$428K
Chelsea BoeSeattle$32K
Anthony LauderLongview$19K
Julie RobertsFederal Way$19K
Gregory ByrdOlympia$17K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →